DocDollars

Kite Pharma, Inc.

CA · United States · Reporting entity ID 100000216809

Total reported 2019–2025
$206.7M
#58 of 2,960 reporting companies — 0.2% of all reported industry payments
$13.4M in general payments across 29,489 records, plus $193.3M in research funding across 9,433 records.

How it breaks down

General payments $13,431,003
Research funding $193,315,082

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Kite Pharma, Inc. reported $206.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #58 of 2,960 reporting companies. 94% of that was research funding and 6% general payments such as consulting, speaking, food and travel. 29,489 general payment records and 9,433 research records were filed.

Common questions about Kite Pharma, Inc.

How much has Kite Pharma, Inc. paid US doctors?

Kite Pharma, Inc. reported $206,746,085 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $13,431,003 in general payments, $193,315,082 in research funding.

How does Kite Pharma, Inc. rank among drug and device companies?

It ranks #58 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Kite Pharma, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.